Dxcover: Ron Andrews
Glasgow, Scotland-based diagnostics firm Dxcover has named Ron Andrews non-executive chair to support its business operations and long-term goals. He was most recently CEO of Oncocyte. Before that, he held leadership positions at the Bethesda Group, Thermo Fisher Scientific, GE, Roche Diagnostics, Abbott Diagnostics, and other firms. Dxcover is developing liquid biopsy tests for the early detection of multiple cancers and has created a multiomic spectral analysis platform leveraging infrared spectroscopy.